Franklin Resources
RXRX icon

Franklin Resources’s Recursion Pharmaceuticals RXRX Stock Holding History

Franklin Resources’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
37,916
+7,525
+25% +$29.1K ﹤0.01% 2898
2025
Q4 		$124K Sell
30,391
-65,755
-68% -$326K ﹤0.01% 2874
2025
Q3 		$469K Buy
96,146
+12,685
+15% +$66.6K ﹤0.01% 2457
2025
Q2 		$422K Buy
83,461
+152
+0.2% +$747 ﹤0.01% 2399
2025
Q1 		$441K Buy
83,309
+7,530
+10% +$54.9K ﹤0.01% 2317
2024
Q4 		$512K Buy
75,779
+56,816
+300% +$382K ﹤0.01% 2280
2024
Q3 		$127K Buy
18,963
+7,027
+59% +$50.4K ﹤0.01% 2724
2024
Q2 		$89.5K Buy
+11,936
New +$104K ﹤0.01% 2688

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources's RXRX Position: Q1 2026 in Review

Franklin Resources increased its Recursion Pharmaceuticals (RXRX) stake by 25% in Q1 2026, buying an estimated $29.1K and bringing the position to 37,916 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #2898.

Franklin Resources first reported a position in RXRX in Q2 2024 and has held it in 8 quarters since. The position peaked at $512K in Q4 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Franklin Resources held 37,916 shares of Recursion Pharmaceuticals worth $116K as of Q1 2026.
  • Franklin Resources bought 7,525 Recursion Pharmaceuticals shares in Q1 2026, an estimated $29.1K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2898 holding.
  • Franklin Resources first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Franklin Resources's Recursion Pharmaceuticals position peaked at $512K in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.